Jennifer Hartt

Jennifer Hartt, a highly accomplished professional, serves as the Managing Director of the Healthcare Investment Group at Ben Franklin Technology Partners of Southeastern Pennsylvania (SEP). With a focus on life sciences, she oversees investments in companies spanning clinical healthcare IT, medical devices, diagnostics, and therapeutics. Hartt boasts a robust track record, having facilitated over 150 investments totaling more than $40M across 80+ companies since 2006.

Her expertise extends to early-stage boards, as well as debt and equity investment instruments. Hartt plays a pivotal role in evaluating investment opportunities and crafting strategic plans. Furthermore, she contributes her insights as a member of Ben Franklin's Investment Committee for the Global Opportunity Philadelphia Fund I, leading healthcare investments in post-seed opportunities. Additionally, she holds a position on the Investment Committee of the BioInnovation Fund startup based in New Orleans, LA.

Jennifer Hartt's academic background is as impressive as her professional accomplishments. She holds a Master's degree in Biology with a specialization in molecular biology and genetics, along with a Bachelor's degree in Biology, both earned with highest honors from the University of Pennsylvania. Her educational journey also included studies at Hampshire College.

Before spearheading the Healthcare Investment Group, Hartt held a Director role in the all-sector Investment Group at Ben Franklin. She brings a wealth of experience in life sciences, rooted in ten years of clinical and lab research work complemented by computing expertise. Transitioning to technology transfer, university equity management, and consulting for businesses of varying scales, Hartt's career trajectory underscores her versatility and proficiency in the field.

Jennifer Hartt is a distinguished speaker, domestically and internationally renowned for her insights on mathematical modeling in valuation, negotiation, and intellectual property asset pricing. Her contributions extend to serving on funding and investment committees, such as the Coulter Foundation translational funding at Drexel University. Beyond her professional endeavors, Hartt actively engages in non-profit cultural organization boards and educational initiatives, reflecting her commitment to community involvement and education.

Overall, Jennifer Hartt emerges as a multifaceted professional with deep-rooted expertise in healthcare investments, strategic planning, and life sciences. Her academic prowess, combined with a diverse industry background, positions her as a respected figure in the realm of investment and technology transfer.